Free Trial

Pediatrix Medical Group (MD) Stock Forecast & Price Target

Pediatrix Medical Group logo
$14.42 -0.07 (-0.48%)
(As of 10:45 AM ET)

Pediatrix Medical Group - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
4
Buy
1

Based on 5 Wall Street analysts who have issued ratings for Pediatrix Medical Group in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 4 have given a hold rating, and 1 has given a buy rating for MD.

Consensus Price Target

$16.10
11.65% Upside
According to the 5 analysts' twelve-month price targets for Pediatrix Medical Group, the average price target is $16.10. The highest price target for MD is $18.00, while the lowest price target for MD is $15.00. The average price target represents a forecasted upside of 11.65% from the current price of $14.42.
Get the Latest News and Ratings for MD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Pediatrix Medical Group and its competitors.

Sign Up

MD Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$16.10$10.90$9.30$16.75
Forecasted Upside11.65% Upside-15.50% Downside-17.77% Downside90.77% Upside
Consensus Rating
Hold
Hold
Hold
Moderate Buy

MD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Pediatrix Medical Group Stock vs. The Competition

TypePediatrix Medical GroupMedical CompaniesS&P 500
Consensus Rating Score
2.20
2.80
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside11.11% Upside26,931.55% Upside9.81% Upside
News Sentiment Rating
Positive News

See Recent MD News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/19/2024Mizuho
2 of 5 stars
 Boost TargetNeutral ➝ Neutral$13.00 ➝ $15.00+3.59%
11/5/2024UBS Group
4 of 5 stars
 Boost TargetNeutral ➝ Neutral$10.50 ➝ $16.50+6.80%
11/5/2024Jefferies Financial Group
2 of 5 stars
 Boost TargetBuy ➝ Buy$14.00 ➝ $18.00+18.89%
11/4/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$9.00 ➝ $15.00+1.63%
11/4/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$13.00 ➝ $16.00+7.10%
2/22/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$27.00 ➝ $23.00+45.85%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:04 AM ET.


MD Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Pediatrix Medical Group is $16.10, with a high forecast of $18.00 and a low forecast of $15.00.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pediatrix Medical Group in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" MD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MD, but not buy additional shares or sell existing shares.

According to analysts, Pediatrix Medical Group's stock has a predicted upside of 11.65% based on their 12-month stock forecasts.

Over the previous 90 days, Pediatrix Medical Group's stock had 1 upgrade by analysts.

Pediatrix Medical Group has been rated by research analysts at Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, Mizuho, Truist Financial, and UBS Group in the past 90 days.

Analysts like Pediatrix Medical Group less than other "medical" companies. The consensus rating for Pediatrix Medical Group is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MD compares to other companies.


This page (NYSE:MD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners